2010Zhonghua zhongliu fangzhi zazhiRequires access

Effects of HER-2 RNA interference on HER-2-positive breast cancer cell sensitivity to chemotherapeutic agent

Jie You

Open publisher page 0 citations

Abstract

OBJECTIVE:To study the effects HER-2 gene RNA interference (RNAi) on the chemo-sensitivity of HER-2-positive breast cancer cell. METHODS:A plasmid vector capable of mediating HER-2 RNAi was constructed,and HER-2 positive breast cancer cell line SKBR-3 was transfected with constructed vector. The expression of HER-2 mRNA and protein was analyzed by RT-PCR and Western blotting; Also,transfected cells were co-cultured with different concentrations of epirubicin and the growth of SKBR-3 cells was analyzed by MTT. RESULTS:The expression of HER-2 mRNA and HER-2 protein was downregulated about 60% and 55%,respectively,in response to vector-mediated HER-2 RNAi. Furthermore,the chemo-sensitivity to epirubicin of the SKBR-3 cell was enhanced significantly by HER-2 gene RNAi and the IC50 was 0.25 μg/μL. CONCLUSION:HER-2 is a good target for RNAi and RNAi,targeting HER-2 gene can cause HER-2 positive breast cancer cell growth inhibition and increasing sensitivity to chemotherapeutics.

About this research paper

What this paper is about

OBJECTIVE:To study the effects HER-2 gene RNA interference (RNAi) on the chemo-sensitivity of HER-2-positive breast cancer cell. METHODS:A plasmid vector capable of mediating HER-2 RNAi was constructed,and HER-2 positive breast cancer cell line SKBR-3 was transfected with constructed vector. The expression of HER-2 mRNA and protein was analyzed by RT-PCR and Western blotting; Also,transfected cells were co-cultured with different concentrations of epirubicin and the growth of SKBR-3 cells was analyzed by MTT. RESULTS:The expression of HER-2 mRNA and HER-2 protein was downregulated about 60% and 55%,respectively,in response to vector-mediated HER-2 RNAi. Furthermore,the chemo-sensitivity to epirubicin of the SKBR-3 cell was enhanced significantly by HER-2 gene RNAi and the IC50 was 0.25 μg/μL. CONCLUSION:HER-2 is a good target for RNAi and RNAi,targeting HER-2 gene can cause HER-2 positive breast cancer cell growth inhibition and increasing sensitivity to chemotherapeutics.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To study the effects HER-2 gene RNA interference (RNAi) on the chemo-sensitivity of HER-2-positive breast cancer cell. METHODS:A plasmid vector capable of mediating HER-2 RNAi was constructed,and HER-2 positive breast cancer cell line SKBR-3 was transfected with constructed vector. The expression of HER-2 mRNA and protein was analyzed by RT-PCR and Western blotting; Also,transfected cells were co-cultured with different concentrations of epirubicin and the growth of SKBR-3 cells was analyzed by MTT. RESULTS:The expression of HER-2 mRNA and HER-2 protein was downregulated about 60% and 55%,respectively,in response to vector-mediated HER-2 RNAi. Furthermore,the chemo-sensitivity to epirubicin of the SKBR-3 cell was enhanced significantly by HER-2 gene RNAi and the IC50 was 0.25 μg/μL. CONCLUSION:HER-2 is a good target for RNAi and RNAi,targeting HER-2 gene can cause HER-2 positive breast cancer cell growth inhibition and increasing sensitivity to chemotherapeutics.

Key concepts: RNA interference, Transfection, Molecular biology, Epirubicin, Biology, Small interfering RNA, Cell culture, Cancer research

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of HER-2 RNA interference on HER-2-positive breast cancer cell sensitivity to chemotherapeutic agent — Research Paper | ScholarLens